Electromed CCO Christopher Holland to depart June 23; receives $117,937 severance plus accelerated vesting

Electromed, Inc.

Christopher G. Holland's employment ends June 23, 2023 under mutual separation agreement.
Lump-sum severance includes $89,175 target bonus and $28,762 for COBRA premiums.
Accelerated vesting of unvested equity eligible to vest by July 1, 2023; remainder forfeited.
Holland remains bound by non-competition, IP, and confidentiality agreements.
Agreement includes cooperation with transition and release of all claims against Electromed.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Christopher G. Holland

Chief Commercial Officer

ELMD · Electromed, Inc.

Effective: 2023-06-23
Filed: June 15, 2023, 7:59 PM ET

On June 13, 2023, Electromed, Inc. (the “Company”) reached a mutual agreement with its Chief Commercial Officer, Christopher G. Holland, to end his employment effective as of June 23, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Christopher G. Holland departed as Chief Commercial Officer at Electromed, Inc..

Action: end his employment
Role: Chief Commercial Officer

Exact text from the filing

On June 13, 2023, Electromed, Inc. (the “Company”) reached a mutual agreement with its Chief Commercial Officer, Christopher G. Holland, to end his employment effective as of June 23, 2023.

View on SEC.gov

Electromed, Inc. filing history →

Source: SEC EDGAR

accession 0000897101-23-000248

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.